Skip to main content

Advertisement

Peer Review reports

From: Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Original Submission
19 Mar 2018 Submitted Original manuscript
21 Apr 2018 Author responded Author comments - Rui-Lian Chen
Resubmission - Version 2
21 Apr 2018 Submitted Manuscript version 2
30 Jul 2018 Reviewed Reviewer Report - Junling Li
16 Aug 2018 Reviewed Reviewer Report - Reviewer 2
16 Sep 2018 Author responded Author comments - Rui-Lian Chen
Resubmission - Version 3
16 Sep 2018 Submitted Manuscript version 3
24 Sep 2018 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
12 Nov 2018 Editorially accepted
26 Nov 2018 Article published 10.1186/s12885-018-5078-y

You can find further information about peer review here.

Back to article page